Nissen, Johanna C <br/><br/>
The risk of infections in hematologic patients treated with rituximab is not influenced by cumulative rituximab dosage - a single center experience.  [electronic resource] 

 -  BMC infectious diseases  Jul 2014 
 - 364 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2334 
<br/><br/><label>Standard No.: </label>10.1186/1471-2334-14-364  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Agents--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Germany<br/>Humans<br/>Immunocompromised Host<br/>Lymphoma, B-Cell--drug therapy<br/>Male<br/>Middle Aged<br/>Prednisone--administration & dosage<br/>Retrospective Studies<br/>Rituximab